BOSTON (April 26, 2022)—Biofourmis, a provider of virtual care and digital medicine, today announced it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round, which will help fuel the company’s next phase of growth. Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr.

LOUISVILLE, Ky. (April 21, 2022)—Humana Inc. today announced that it has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice to divest a majority interest in the hospice and personal care divisions of Humana’s Kindred at Home subsidiary (KAH hospice). These divisions include patient-centered services for hospice, palliative, community and personal care.